Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Inhibrx Biosciences, Inc. (NASDAQ: INBX)
INBX Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-66.20%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-21.20%
INBX Stock Analysis
INBX
PE Ratio:
INBX
PEG Ratio:
Not Available
INBX
Forward EPS Growth (12 month):
0.00%
INBX
PS Ratio:
1074.6
INBX
PSG Ratio:
Not Available
INBX
Forward Revenue Growth (12 month):
0.00%
INBX Articles
No data was found